Tag Archives: Alzheimer’s Research and Therapy

Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)

Posted on August 5, 2020 by Dementia and Elderly Care News

Summary The Lancet Commission on Dementia Prevention, Intervention, and Care has updated evidence on modifiable risk factors the prevention of dementia, and the “life-course model of dementia prevention”. There were nine modifiable risk factors for reducing the risk of dementia … Continue reading →

Posted in Commissioning, Depression, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Nutrition, Person-Centred Care, Pharmacological Treatments, Quick Insights, Statistics, Systematic Reviews, UK, Universal Interest | Tagged Ageing Population, Ageing Population Carer Support, Air Pollution, Air Pollution and Risk of Dementia, Alzheimer's and Dementia: The Journal of the Alzheimer's Association, Alzheimer's Research and Therapy, Alzheimer’s Therapeutic Research Institute: University of Southern California, Barriers to Support, Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Blood Pressure, BMJ Publishing Group Ltd, Burden of Multimorbidity, Canada, Capital Medical University (Beijing China), Caring for Family Carers, China, Chinese University of Hong Kong, Chronic Traumatic Brain Injury, Cognitive Decline and Dementia: Risk Reduction, Cumulative Benefit of Reducing Risk Factors, CVDPREVENT: National Primary Care Audit, Daping Hospital, Delivery of Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Dementia and COVID-19, Dementia and Multimorbidity, Dementia and Sensory Loss, Dementia Policy, Dementia Post-Diagnostic Care and Support, Dementia Prevalence Projections: LMIC Countries, Dementia Prevalence Projections: LMIC Countries (Low and Middle Income Countries), Dementia Prevention, Dementia Research, Dementia Research Priorities, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Department of Hygiene and Epidemiology: University of Ioannina Medical School, Diet and Dementia, Dietary Factors, Excessive Alcohol Consumption, Family Carers, Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER), France, Fudan University (Shanghai China), Geriatric Care and Research Organisation (GeriCaRe), Greece, Harvard Medical School, Head Injury, Healthy Ageing, Healthy Ageing 2020 International Conference [Online] (GeriCaRe), Healthy and Active Ageing: Life-Course Approach (WHO), Healthy Lifestyles, Hippocampal Sclerosis Associated with TDP-43 Proteinopathy, Holistic Post-Diagnostic Care, Hong Kong, Huashan Hospital (Shanghai China), Huazhong University of Science and Technology (Wuhan China), Hyperhomocysteinaemia, Increasing Knowledge of Risk and Protective Factors, Journal of Geriatric Care and Research (JGCR), Journal of Neurology, Journal of Neurology Neurosurgery and Psychiatry, Lancet, Lancet Commission on Dementia Prevention Intervention and Care, Lancet Commission on Dementia Prevention Intervention and Care (LCDPIC), Later Life, LCDPIC: Lancet Commission on Dementia Prevention Intervention and Care, Life-Course Approach to Healthy and Active Ageing, Life-Course Model of Dementia Prevention: Twelve Risk Factors, Life-Course Model of Dementia Prevention, Lifestyle Factors, Lifestyle Risk Factors, Lifestyle Weight Management, Limbic-Predominant Age-Related TDP-43 Encephalopathy (LATE), LMICs, Loneliness, Loneliness and Social Isolation, Loneliness Harms Health, Massachusetts General Hospital, Maximising Benefits to People Living With Dementia and Their Families of Seeking and Receiving a Diagnosis of Dementia, McGill Center for Studies in Aging: McGill University, McGill University, MCI: Mild Cognitive Impairment, Medical Research Council, Mediterranean Diet, Midlife Hypertension, Mild Cognitive Impairment (MCI), Modifiable Risk Factors, Mortality Risk Factors, Multidomain Lifestyle Intervention Trials for Dementia Risk Reduction and Prevention, National University of Singapore, Neurological Disorders, Neuroprotective Lifestyles, Neuropsychiatric Symptoms, Neuropsychiatric Symptoms in People With Dementia, Neuropsychiatric Symptoms of Alzheimer’s Disease, Obesity, Obesity Risk Factor, Overlapping Risk Factors, PAF Calculations, PAF for 12 Dementia Risk Factors, People With Dementia and Family Carers, Physical Activity and Health Benefits, Physical Activity Before Dementia, Physical Exercise, Physical Exercise Programmes, Physical Inactivity, Population Attributable Fraction (PAFs) of Dementia, Potentially Modifiable Socio-Environmental Risk Factors for Dementia, Preclinical Dementia and Associated Lifestyle Changes, Prevention, Prevention Agenda, Prevention Agenda Linking Dementia and Other Non-Communicable Diseases, Prevention Approaches, Prevention Better Than Cure, Prevention of Dementia, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Prevention Programmes, Preventive Care, Primary Care Cardiovascular Society, Psychiatry of Late Life Social Care and Society: University of Manchester, Psychosocial and Lifestyle-Related Risk Factors, Psychosocial Protective and Risk Factors, Public Health, Public Health Interventions, Purpan University Hospital (Toulouse France), Qingdao Municipal Hospital, Qingdao University (China), Quality of Life for People Affected by Dementia by Preventing and Treating Negative Consequences of Dementia, Quality of Life for People Affected by Dementia by Promoting Functional Capabilities and Independence, Reducing the Incidence of Dementia, Risk and Protective Factors, Risk Factors, Risk Factors and Preventive Interventions for Cognitive Impairment, Risk Factors and Preventive Interventions for Dementia, Risk Reduction of Cognitive Decline and Dementia, School of Public Health: Tongji Medical College, Sedentary Lifestyles, Sensory Impairments, Shanghai Medical College, Singapore, Smoking Cessation, Social Activities, Social Epidemiology, Social Isolation, Supporting Healthy Lifestyles, Supporting People Affected by Dementia, Systematic Reviews and Meta-Analyses, T2DM, Tackling Inequality and Protecting People With Dementia, Third Military Medical University (Chongqing China), Tobacco, Tobacco Cessation, Tobacco Consumption, Traumatic Brain Injury, Traumatic Brain Injury and Subsequent Dementia, Twelve Risk Factor Life-Course Model of Dementia Prevention, Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes: Prevention, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, United States, University Hospital of Montpellier, University of Cambridge, University of Ioannina Medical School, University of Manchester, University of Southern California, University of Toulouse III, USA, Weight Management, Wellcome Trust Behavioural and Clinical Neuroscience Institute: University of Cambridge, World-Wide FINGERS (WW-FINGERS), World-Wide FINGERS Network, Xuan Wu Hospital, Yong Loo Lin School of Medicine: National University of Singapore | Leave a comment

Dementia Medication De-Listed in France: Untruth, Half-Truth or Paternalistic News Blackout? (BBC News / Prescrire / ADI / Inside Health / JAMA Network Open)

Posted on October 18, 2018 by Dementia and Elderly Care News

Summary Early evening headlines yesterday, on BBC Radio 4 news, announced the “shocking” news that drugs for Alzheimer’s Disease / dementia had been de-listed in France. This story has not been followed-up, and appears to have been dropped quietly; although … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Universal Interest | Tagged Adverse Drug Reactions, Adverse Effects, Alpha-7 Nicotinic Acetylcholine Receptor (α7nAChR), Alzheimer's Disease: Monotherapy Versus Combination Therapy, Alzheimer's Research and Therapy, Alzheimer’s Disease International (ADI), Alzheimer’s Disease International (ADI) Campaigns, American Family Physician, Anti-Dementia Medication, Augusta University, BBC Radio 4, BBC Radio 4's Inside Health Programme, BBC Radio 4’s PM Programme, Big Pharma, BMJ, BMJ Publishing Group Ltd, British Medical Journal (BMJ), Cambridge Institute of Public Health: University of Cambridge, Care of the Elderly Medicine Department: Royal Wolverhampton NHS Trust, Cholinergic-Nicotinic System, Choosing Wisely, Clinic for Medicine of the Elderly (Hannover), Conflict of Interests, Conflicts of Interest, Department of Behavioral Neuroscience and Drug Development: Polish Academy of Sciences, Department of Psychiatry and Behavioral Health: Marshfield Clinic Health System, Department of Psychiatry and Behavioral Sciences: George Washington University School of Medicine and Health Sciences, Department of Psychiatry and Health Behavior: Augusta University, Department of Public Health and Primary Care: University of Cambridge, Deprescribing, Donepezil, Donepezil-Memantine Combination, Donepezil-Memantine: Monotherapy Versus Combination Therapy, Drug Efficacy, Drug Side-Effects, Drugs Alleged to Raise False Hopes (Speculative Construct), Family Medicine Residency Program: Southern Illinois University School of Medicine, Family Physicians Inquiries Network (FPIN), Formindep: Non-Profit Organisation Promoting Independence From Industry Influence, France, France's National Authority for Health (HAS), French Ministry of Health and Solidarity, French National Dementia Guidelines, Galantamine, Galantamine-Memantine Combination Versus Donepezil-Memantine Combination, Galantamine-Memantine Drug Combination, George Washington University School of Medicine and Health Sciences, Germany, Glutamatergic Receptor Systems, Glutamatergic System, Harms of Too Much Medicine, Institute of Pharmacology: Polish Academy of Sciences, JAMA Network Open, Janssen Research and Development, Journal of Geriatric Care and Research (JGCR), Keck School of Medicine: University of Southern California, KYNA/3-HK, KYNA/KYN, KYNA/QUIN, Kynurenic Acid, Kynurenine Pathway, Marshfield Clinic Health System (USA), Medical College of Georgia: Augusta University, Memantine, Ministry of Health and Solidarity (France), Mismatch Negativity (MMN), Mount Sinai Medical Center (New York), National Institutes of Health (NIH), National Institutes of Health (US), Neurotransmitter Systems in Alzheimer’s Disease, New Cross Hospital, New Cross Hospital: Royal Wolverhampton NHS Trust, NMDA (N-Methyl-D-Aspartate), Over-Treatment, Oxidative Stress, Paola Barbarino: Alzheimer’s Disease International, Pharmaceutical Journal, Poland, Polish Academy of Sciences, Prescrire in English [the Prescriber] / Rev. Prescrire, Psychosocial Approaches to Dementia Support, Psychosocial Approaches to Dementia: Storytelling Music and Song, Reducing Waste in Dementia Care, Reducing Waste in the NHS, Rivastigmine, Royal Wolverhampton NHS Trust, Serge Gauthier: ADI’s Medical and Scientific Advisory Panel (MSAP), Society of Biological Psychiatry (SOBP), Southern Illinois University, Southern Illinois University School of Medicine, Synaptec Inc (Florida), Too Much Medicine, United States, University of Alabama at Birmingham, University of Cambridge, University of Southern California, USA | Leave a comment

More On the Association Between Periodontitis and the Risk of Developing Alzheimer’s Disease (NHS Choices / Alzheimer’s Research and Therapy)

Posted on August 25, 2017 by Dementia and Elderly Care News

Summary Analysis of data from the National Health Insurance Research Database (NHIRD) of Taiwan indicates that patients with chronic gum disease (periodontitis) are at higher risk of developing Alzheimer’s Disease. “These findings highlight the need to prevent progression of periodontal disease… … Continue reading →

Posted in For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Parkinson's Disease, Quick Insights, Universal Interest | Tagged Alzheimer's Disease and Chronic Periodontitis, Alzheimer's Research and Therapy, Behind the Headlines, Chronic Periodontitis, Chung Shan Medical University (Taiwan), Chung Shan Medical University Hospital (Taiwan), Dementia Risk Factors, Dental and Oral Health, Dental Health, Dental Healthcare, Dental Hygiene, Dental Status, Department of Dentistry: Chung Shan Medical University Hospital, Department of Physical Medicine and Rehabilitation: Tri-Service General Hospital (Taiwan), Epidemiology, Epidemiology and Statistics, Gum Disease (Periodontitis), Inflammation, Inflammation and Neurodegenerative Diseases, Inflammatory Response, Lifestyle Risk Factors, Modifiable Risk Factors, National Defense Medical Center (Taiwan), National Health Insurance Research Database (NHIRD) of Taiwan, Oral Health, Oral Health and Cognitive Function, Oral Healthcare, Oral Hygiene, Parkinson's Disease and Chronic Periodontitis, PeerJ, Periodontal Inflammatory Disease, Periodontitis, Periodontitis and Risk of Developing Alzheimer’s Disease, Risk Factors, Risk Factors and Preventive Interventions for Alzheimer Disease, Risk Factors for Alzheimer's Diseease, Risk Factors for Parkinson's Disease, School of Dentistry: Chung Shan Medical University, School of Medicine: National Defense Medical Center, Section of Dentistry: Zuoying Branch of Kaohsiung Armed Forces General Hospital, Taiwan, Zuoying Branch of Kaohsiung Armed Forces General Hospital (Taiwan) | Leave a comment

Tag Archives: Alzheimer’s Research and Therapy

Dementia Medication De-Listed in France: Untruth, Half-Truth or Paternalistic News Blackout? (BBC News / Prescrire / ADI / Inside Health / JAMA Network Open)

More On the Association Between Periodontitis and the Risk of Developing Alzheimer’s Disease (NHS Choices / Alzheimer’s Research and Therapy)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites